41.3 Plantar Fasciitis, Shin Splints & Overuse Syndromes

ABFM Family Medicine Certification Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Structure, Blueprint & Clinical Decision-Making

1.1 Exam Blueprint, FMCLA vs. One-Day Exam & Board Scoring 1.2 Clinical Reasoning, Test-Taking Strategy & Ambiguity Management 1.3 Evidence-Based Medicine & Clinical Practice Guidelines in Primary Care

2 Chapter 2: Healthcare Systems, Practice Management & Quality

2.1 Practice Management, Billing, Coding & Documentation 2.2 Quality Improvement, Patient Safety & Diagnostic Stewardship 2.3 Interprofessional Team-Based Care & Care Coordination

3 Chapter 3: Ethics, Law, Biostatistics & Health Equity

3.1 Medical Ethics, Informed Consent & Surrogate Decision-Making 3.2 Biostatistics, Clinical Epidemiology & Diagnostic Test Interpretation 3.3 Social Determinants of Health, Health Equity & Cultural Humility 3.4 Physician Wellness, Burnout Prevention & Professionalism

4 Chapter 4: Lifestyle Counseling & Behavior Change

4.1 Alcohol Use Screening & Brief Intervention 4.2 Illicit Drug & Cannabis Counseling 4.3 Tobacco & Vaping Cessation Counseling

5 Chapter 5: Nutrition, Physical Activity & Chronic Disease Prevention

5.1 Dietary Counseling for Obesity & Chronic Disease Prevention 5.2 Exercise Prescription & Physical Activity Counseling 5.3 Genetic Risk Assessment & Family History Counseling

6 Chapter 6: Routine Adult Immunizations

6.1 ACIP Adult Respiratory Vaccines: Influenza, COVID-19, RSV & Pneumococcal 6.2 ACIP Adult Non-Respiratory Vaccines: Tdap, Shingrix, HPV & Hep B 6.3 Immunizations in Special Populations: Pregnancy, Asplenia & Immunocompromise

7 Chapter 7: Pediatric Health Maintenance & Surveillance

7.1 Newborn Examination & Early Postnatal Care 7.2 Well-Child Care, Developmental Surveillance & Milestones 7.3 Pediatric & Adolescent Screening: Vision, Hearing, Anemia & Lead 7.4 Pediatric Oral Health, Dental Screening & Fluoride

8 Chapter 8: Behavioral Health & Safety Screening

8.1 Primary Care Depression, Anxiety & Behavioral Health Screening 8.2 Domestic Violence, Intimate Partner Violence & Firearm Safety 8.3 Occupational Health & Recreational Safety Counseling

9 Chapter 9: Adult Preventive Screening: Cardiovascular & Metabolic

9.1 Cardiovascular Disease & Hypertension Screening 9.2 Type 2 Diabetes Screening & Prediabetes Risk Stratification 9.3 Abdominal Aortic Aneurysm & Osteoporosis Screening

10 Chapter 10: Adult Cancer Screening: Breast & Gynecologic

10.1 Breast Cancer Screening & Risk-Assessment 10.2 Cervical Cancer Screening & ASCCP Algorithms 10.3 Skin Cancer Clinical Assessment & Counseling

11 Chapter 11: Adult Cancer Screening: Colorectal, Lung & Prostate

11.1 Colorectal Cancer Screening Modalities & Intervals 11.2 Lung Cancer Screening with Low-Dose CT 11.3 Prostate Cancer Screening & Shared Decision-Making

12 Chapter 12: Sexual Health, Infectious Disease Screening & Contraception

12.1 Sexual Health Counseling & Risk-Reduction Strategies 12.2 STI Screening: Chlamydia, Gonorrhea, Syphilis & Trichomoniasis 12.3 Bloodborne Infectious Disease Screening: HIV & Hepatitis C

13 Chapter 13: Reproductive Life Planning, Lactation & Preoperative Care

13.1 Preconception Planning & Comprehensive Contraception Management 13.2 Lactation Support & Breastfeeding Counseling 13.3 Preoperative Medical Evaluation & Pre-Participation Sports Exam

14 Chapter 14: Emergent Cardiovascular Conditions

14.1 Acute Coronary Syndromes & Myocardial Infarction 14.2 Acute Chest Pain Risk Stratification & Triage 14.3 Acute or Critical Valvular Heart Emergencies

15 Chapter 15: Cardiac Arrhythmias, Heart Failure & Hypertensive Crises

15.1 Acute Atrial & Ventricular Arrhythmias 15.2 Acute Decompensated Heart Failure & Cardiogenic Shock 15.3 Hypertensive Emergency & Urgency Management

16 Chapter 16: Vascular & Thromboembolic Emergencies

16.1 Pulmonary Embolism & Deep Vein Thrombosis 16.2 Acute Aortic Syndromes & Peripheral Vascular Emergencies 16.3 Critical Limb Ischemia & Acute Arterial Occlusion

17 Chapter 17: Neurologic Emergencies: Stroke & Altered Consciousness

17.1 Acute Ischemic Stroke & Intracranial Hemorrhage 17.2 Syncope Evaluation & Status Epilepticus 17.3 Acute Delirium, Encephalopathy & Severe Confusion

18 Chapter 18: Neurologic Trauma & Acute Cranial Emergencies

18.1 Concussion, Moderate-to-Severe TBI & Intracranial Injury 18.2 Thunderclap & Acute Severe Secondary Headaches 18.3 Acute Ophthalmologic Emergencies

19 Chapter 19: Acute Abdominal, Pelvic & Gastrointestinal Emergencies

19.1 Acute Abdominal & Pelvic Pain Triage 19.2 Upper & Lower Gastrointestinal Bleeding 19.3 Acute Hepatic Failure, Cholangitis & Severe Jaundice

20 Chapter 20: Acute Pulmonary & Airway Emergencies

20.1 Acute Hypoxic Respiratory Failure & ARDS 20.2 Severe Community-Acquired Pneumonia & Empyema 20.3 Acute Severe Epistaxis & Airway Obstruction

21 Chapter 21: Acute Traumatic Injuries & Wound Care

21.1 Major Trauma Resuscitation & Initial Assessment 21.2 Burn Assessment, Inhalation Injury & Resuscitation 21.3 Laceration Management, Complex Wounds & Animal Bites

22 Chapter 22: Acute Orthopedic & Musculoskeletal Emergencies

22.1 Acute Ambulatory Fractures & Initial Splinting 22.2 Compartment Syndrome & Major Orthopedic Trauma 22.3 Septic Arthritis & Acute Microcrystalline Crises

23 Chapter 23: Severe Infections, Sepsis & Systemic Emergencies

23.1 Sepsis, Septic Shock & Initial Fluid Resuscitation 23.2 Necrotizing Soft Tissue Infections & Severe CNS Infections 23.3 Anaphylaxis Diagnosis, Epinephrine Dosing & Airway Protection

24 Chapter 24: Metabolic, Endocrine & Electrolyte Emergencies

24.1 Diabetic Ketoacidosis & Hyperosmolar Hyperglycemic State 24.2 Critical Electrolyte Emergencies: Dyskalemias & Dysnatremias 24.3 Severe Calcium Abnormalities & Acute Adrenal Crisis

25 Chapter 25: Hematologic, Urologic & Dental Emergencies

25.1 Severe Symptomatic Anemias & Coagulopathic Emergencies 25.2 Testicular Torsion, Priapism & Acute Urinary Retention 25.3 Urgent Odontogenic Infections & Dental Trauma

26 Chapter 26: Psychiatric, Behavioral & Obstetric/Gynecologic Emergencies

26.1 Suicidal Ideation, Acute Agitation & Behavioral Emergencies 26.2 Acute Physical & Sexual Assault Care 26.3 Life-Threatening Vaginal Bleeding & Ectopic Pregnancy 26.4 Environmental Heat Stroke & Severe Hypothermia

27 Chapter 27: Acute Head, Neck & Neurologic Symptoms

27.1 Primary Acute Headaches: Migraine, Tension & Cluster 27.2 Concussion & Minor Closed Head Injury Evaluation 27.3 Transient Ischemic Attack Evaluation & ABCD2 Risk Scoring

28 Chapter 28: Acute Cranial Nerves, Hearing & Sensory Symptoms

28.1 Peripheral Neuropathies: Bell's Palsy, Carpal Tunnel & Radiculopathy 28.2 Acute Tinnitus, Sudden Sensorineural Hearing Loss & Cerumen Impaction 28.3 Acute Dizziness, Benign Paroxysmal Positional Vertigo & Vestibular Neuritis

29 Chapter 29: Acute Upper Respiratory Tract Infections

29.1 Acute Viral Rhinosinusitis vs. Bacterial Rhinosinusitis 29.2 Acute Pharyngitis: Group A Streptococcus & Centor Criteria 29.3 Acute Otitis Media, Otitis Externa & Serous Effusion

30 Chapter 30: Acute Lower Respiratory Infections & Cough

30.1 Influenza, COVID-19 & Viral Respiratory Syndromes 30.2 Acute Bronchitis & Lower Respiratory Tract Infections 30.3 Ambulatory Community-Acquired Pneumonia

31 Chapter 31: Allergic, Nasal & Non-Infectious Pulmonary Conditions

31.1 Allergic Rhinitis & Acute Non-Anaphylactic Allergic Reactions 31.2 Acute Dyspnea in Ambulatory Care 31.3 Interstitial Lung Diseases & Sarcoidosis Presentation

32 Chapter 32: Acute Chest, Cardiac & Vascular Symptoms

32.1 Palpitations Evaluation & Arrhythmia Triage in Primary Care 32.2 Deep Vein Thrombosis & Superficial Thrombophlebitis 32.3 Ambulatory Hypotension & Orthostasis Evaluation

33 Chapter 33: Acute Upper Gastrointestinal Conditions

33.1 Peptic Ulcer Disease & Gastritis 33.2 Dysphagia, Esophagitis & Acute Esophageal Disorders 33.3 Acute Nausea, Vomiting & Foodborne Illness

34 Chapter 34: Acute Lower Gastrointestinal Conditions

34.1 Acute Infectious Diarrhea & Gastroenteritis 34.2 Acute Constipation & Functional Bowel Changes 34.3 Ano-Rectal Disorders: Hemorrhoids, Fissures, Abscesses & Pruritus Ani

35 Chapter 35: Inflammatory, Functional & Malabsorptive GI Disorders

35.1 Acute Flares of Inflammatory Bowel Disease 35.2 Irritable Bowel Syndrome: Diagnosis, Subtyping & Management 35.3 Celiac Disease & Malabsorption Syndromes

36 Chapter 36: Acute Abdominal, Hepatic & Biliary Disorders

36.1 Ambulatory Abdominal & Pelvic Pain Triage 36.2 Acute Cholecystitis, Biliary Colic & Pancreatitis 36.3 Acute Liver Injury & Viral Hepatitis

37 Chapter 37: Acute Abdominal Wall, Hernias & Dental Conditions

37.1 Abdominal Wall, Inguinal & Ventral Hernias 37.2 Acute Dental Pain, Odontogenic Abscess & Aphthous Ulcers 37.3 Acute Edema: Unilateral vs. Bilateral Diagnostic Evaluation

38 Chapter 38: Acute Infectious Dermatoses

38.1 Bacterial Skin Infections: Impetigo, Cellulitis & Cutaneous Abscesses 38.2 Fungal Skin Infections: Tinea Corporis, Cruris, Pedis & Onychomycosis 38.3 Viral Cutaneous Infections: Herpes Simplex, Zoster & Molluscum Contagiosum

39 Chapter 39: Inflammatory, Allergic & Autoimmune Dermatoses

39.1 Atopic Dermatitis, Contact Dermatitis & Eczematous Flares 39.2 Non-Infectious Rashes: Urticaria, Drug Eruptions & Erythema Multiforme 39.3 Cutaneous Malignancies & Premalignant Lesions: AK, BCC, SCC & Melanoma

40 Chapter 40: Acute Shoulder, Elbow & Upper Extremity Injuries

40.1 Rotator Cuff Pathology, Tendinopathy & Shoulder Impingement 40.2 Lateral & Medial Epicondylitis, Olecranon Bursitis & Elbow Sprains 40.3 Wrist & Hand Soft-Tissue Injuries: De Quervain, TFCC & Finger Sprains

41 Chapter 41: Acute Knee, Ankle & Lower Extremity Injuries

41.1 Meniscal Tears, Ligamentous Knee Injuries & Patellofemoral Pain 41.2 Ankle Sprains, Ottawa Ankle Rules & Achilles Tendinopathy 41.3 Plantar Fasciitis, Shin Splints & Overuse Syndromes

42 Chapter 42: Acute Ambulatory Fractures & Dislocations

42.1 Distal Radius, Scaphoid & Common Upper Extremity Fractures 42.2 Metatarsal, Clavicle & Common Lower Extremity Fractures 42.3 Joint Dislocation Management: Nursemaid's Elbow & Shoulder Subluxation

43 Chapter 43: Acute Axial Musculoskeletal Pain & Falls

43.1 Acute Low Back Pain: Red Flags, Strain & Disc Herniation 43.2 Acute Cervical Strain, Whiplash & Axial Neck Pain 43.3 Evaluation of Falls in Ambulatory & Older Patients

44 Chapter 44: Acute Inflammatory Arthropathies & Generalized Pain

44.1 Acute Inflammatory Arthritis & Spondyloarthropathies 44.2 Myalgias, Rhabdomyolysis & Post-Viral Pain Syndromes 44.3 Acute Non-Headache Pain Management Strategies

45 Chapter 45: Acute Renal, Urinary & Genitourinary Conditions

45.1 Uncomplicated UTI, Pyelonephritis & Acute Urethritis 45.2 Hematuria Workup & Glomerulonephritis 45.3 Nephrolithiasis & Acute Urinary Tract Obstruction

46 Chapter 46: Acute Male Genitourinary & Prostatic Conditions

46.1 Acute Prostatitis, Epididymitis & Orchitis 46.2 Acute Scrotal Pain: Torsion vs Appendage, BPH & Male Genital Emergencies 46.3 Acute Urinary Retention & Incontinence Evaluation

47 Chapter 47: Acute Women's Health & Early Pregnancy Care

47.1 Early Pregnancy Diagnosis, Dating & Initial Complications 47.2 Abnormal Uterine Bleeding & Acute Menstrual Disorders 47.3 Premenstrual Syndrome & Premenstrual Dysphoric Disorder

48 Chapter 48: Breast Disorders, STIs & Pediatric Elimination

48.1 Palpable Breast Mass, Mastitis & Nipple Discharge 48.2 Sexually Transmitted Infections: Diagnosis, Staging & CDC Guidelines 48.3 Pediatric Enuresis & Encopresis

49 Chapter 49: Systemic Signs, Metabolic Dysregulation & Miscellaneous Infections

49.1 Acute Fever, Sepsis Screening & FUO in Primary Care 49.2 Acute Hyperglycemia & Symptomatic Hypoglycemia 49.3 Electrolyte Abnormalities: Mild-to-Moderate Disturbances 49.4 Vector-Borne, Tick-Borne & Rickettsial Illnesses

50 Chapter 50: Chronic Cardiovascular Diseases: Hypertension & Ischemia

50.1 Essential Hypertension Management: 2025 AHA/ACC Guideline & JNC Strategies 50.2 Chronic Coronary Artery Disease & Post-MI Secondary Prevention 50.3 Chronic Heart Failure: HFrEF, HFpEF & Quadruple GDMT

51 Chapter 51: Chronic Vascular, Valvular & Dyslipidemic Diseases

51.1 Peripheral Arterial Disease & Claudication 51.2 Chronic Valvular Heart Disease & Murmur Evaluation 51.3 Lipid Disorders & ASCVD Risk-Based Statin Therapy

52 Chapter 52: Chronic Respiratory Diseases: Asthma & COPD

52.1 Chronic Asthma Management: GINA Stepwise SMART Therapy 52.2 Chronic Obstructive Pulmonary Disease: GOLD Recommendations 52.3 Solitary Pulmonary Nodule Evaluation & Fleischner Society Criteria

53 Chapter 53: Chronic Metabolic Diseases: Diabetes Mellitus

53.1 Type 2 Diabetes Management: ADA Pharmacotherapy Algorithms 53.2 Type 1 Diabetes: Basal-Bolus Insulin, CGMs & Diabetic Complications 53.3 Diabetic Microvascular & Macrovascular Disease Surveillance

54 Chapter 54: Obesity, Nutrition & Metabolic Bone Diseases

54.1 Medical & Behavioral Management of Obesity & Incretin Mimetics 54.2 Osteoporosis & Metabolic Bone Disease: DEXA, FRAX & Antiresorptives 54.3 Nutritional Deficiencies: Vitamin D, B12, Iron & Malnutrition

55 Chapter 55: Chronic Endocrine Disorders

55.1 Primary & Subclinical Hypothyroidism, Hyperthyroidism & Nodules 55.2 Adrenal Disorders: Addison's Disease & Cushing's Syndrome 55.3 Hypercalcemia, Hyperparathyroidism & Pituitary Disorders

56 Chapter 56: Chronic Kidney Disease & Venous Disorders

56.1 Chronic Kidney Disease: KDIGO Staging & Renoprotective Therapy 56.2 Chronic Venous Insufficiency, Stasis Dermatitis & Lymphedema 56.3 Chronic Electrolyte & Acid-Base Management in CKD

57 Chapter 57: Chronic Gastrointestinal & Hepatic Diseases

57.1 Gastroesophageal Reflux Disease, Barrett's Esophagus & Dyspepsia 57.2 Chronic Liver Disease: MASLD/NAFLD, Cirrhosis & Portal Hypertension 57.3 Viral Hepatitis B & C: Long-Term Monitoring & DAA Therapy

58 Chapter 58: Colorectal Surveillance & Chronic Pancreaticobiliary Care

58.1 Post-Polypectomy Colorectal Polyp Surveillance Guidelines 58.2 Chronic Pancreatitis & Exocrine Pancreatic Insufficiency 58.3 Chronic Nausea, Gastroparesis & Functional GI Disorders

59 Chapter 59: Chronic Musculoskeletal & Rheumatologic Disorders

59.1 Osteoarthritis: Hip, Knee & Hand Management 59.2 Spinal Conditions: Spinal Stenosis, Spondylolisthesis & Compression Fractures 59.3 Chronic Myopathies & Fibromyalgia Syndrome

60 Chapter 60: Chronic Neurologic & Neurodegenerative Disorders

60.1 Dementia: Alzheimer's, Vascular & Lewy Body Disease 60.2 Parkinson's Disease & Essential Tremor 60.3 Epilepsy: Chronic Antiseizure Medications & Post-Stroke Care

61 Chapter 61: Chronic Peripheral Nerves, Pain & Sensory Disorders

61.1 Diabetic & Chronic Peripheral Neuropathies 61.2 Chronic Pain Syndromes & Chronic Daily Headaches 61.3 Chronic Tinnitus, Presbycusis & Persistent Dizziness

62 Chapter 62: Chronic Psychiatric Disorders

62.1 Major Depressive Disorder & Generalized Anxiety Disorder 62.2 Bipolar Disorder: Maintenance Pharmacotherapy & Lithium Monitoring 62.3 Adult & Pediatric Attention-Deficit/Hyperactivity Disorder

63 Chapter 63: Chronic Behavioral Health & Neurodevelopmental Conditions

63.1 Chronic Behavioral Conditions: PTSD, OCD & Somatization 63.2 Autism Spectrum Disorder & Intellectual Disabilities 63.3 Eating Disorders: Anorexia Nervosa, Bulimia & Binge Eating

64 Chapter 64: Chronic Substance Use Disorders & Tobacco Cessation

64.1 Alcohol Use Disorder: Pharmacotherapy & Relapse Prevention 64.2 Opioid & Stimulant Use Disorders: MOUD & Harm Reduction 64.3 Longitudinal Tobacco Cessation Pharmacotherapy

65 Chapter 65: Chronic Dermatologic Conditions

65.1 Acne Vulgaris, Rosacea & Seborrheic Dermatitis 65.2 Chronic Plaque Psoriasis & Biologic Therapies 65.3 Chronic Eczema, Hidradenitis Suppurativa & Cutaneous Lupus

66 Chapter 66: Chronic Reproductive, Infectious & Geriatric Special Care

66.1 Chronic Menstrual Disorders, Infertility & Sexual Dysfunction 66.2 Menopause Management & Hormone Replacement Therapy 66.3 Chronic HIV Infection Management & Primary Care Integration 66.4 Gender-Affirming Primary Care & Hormone Therapy 66.5 Advance Care Planning, Palliative Care & End-of-Life Symptom Control

67 Chapter 67: Continuity Care: Sleep, Fatigue, Cancer, Pregnancy & the Adult Preventive Visit

67.1 Chronic Insomnia & Obstructive Sleep Apnea 67.2 Chronic Malaise, Fatigue & ME/CFS 67.3 Primary Care During Cancer Treatment & Survivorship 67.4 Routine Prenatal Care & Longitudinal Pregnancy Management 67.5 The Periodic Adult Health Examination & Medicare Annual Wellness Visit

41.3 Plantar Fasciitis, Shin Splints & Overuse Syndromes

Key Takeaways Explain This Topic AI

Plantar fasciitis is a degenerative fasciosis of the medial calcaneal tuberosity origin characterized by intense heel pain with the first steps out of bed in the morning; calcaneal spurs are incidental traction osteophytes present in 15% to 25% of asymptomatic individuals and do not correlate with symptoms.

Over 90% of plantar fasciitis cases resolve within 6 to 12 months using conservative therapy: plantar fascia and Achilles stretching, prefabricated orthotics, and night splints; corticosteroid injections carry high risks of plantar fascia rupture (up to 10%) and permanent fat pad atrophy.

Medial tibial stress syndrome (MTSS / 'shin splints') presents with diffuse, dull pain along a broad segment (>5 cm) of the posteromedial tibial border, managed with relative rest and cross-training; tibial stress fractures feature focal point tenderness (<2 cm), pain at rest and night, and a positive hop test.

Tibial stress fractures are risk-stratified by location: posteromedial cortex fractures are low-risk compression injuries healing with conservative care, whereas anterior cortex fractures ('dreaded black line') are high-risk tension injuries prone to nonunion requiring strict non-weight-bearing immobilization or surgical nailing.

Morton neuroma is a compressive perineural fibrosis of the common digital nerve in the third intermetatarsal space; presenting with burning forefoot pain and a feeling of 'walking on a marble', it is diagnosed clinically by the Mulder click and managed with wide toe-box footwear and metatarsal pads.

Last updated: September 2026

Plantar Fasciitis: Pathomechanics & Clinical Evaluation

Plantar fasciitis is the most common cause of inferior heel pain in adults, responsible for more than 1 million clinical visits annually in the United States and affecting approximately 10% of the population over a lifetime.

Functional Anatomy & The Windlass Mechanism

Anatomy : The plantar fascia (plantar aponeurosis) is a dense, thick, multi-layered fibrous band of connective tissue originating predominantly from the medial process of the calcaneal tuberosity . It courses distally across the plantar vault, dividing into five longitudinal digital bands that insert into the plantar plates, fibrous flexor sheaths, and bases of the proximal phalanges of digits 1 through 5.

The Windlass Mechanism : Described by Hicks in 1954, the Windlass mechanism is essential for normal human bipedal locomotion. During the terminal stance and "toe-off" phases of gait, extension (dorsiflexion) of the metatarsophalangeal (MTP) joints—especially the first MTP joint—winds the plantar fascia around the metatarsal heads like a cable on a windlass. This winding shortens the distance between the calcaneus and the metatarsals, elevating the medial longitudinal arch , supinating the subtalar joint, and transforming the flexible, shock-absorbing foot into a rigid structural lever for forward propulsion. THE WINDLASS MECHANISM

• Terminal Stance / Toe-Off Phase: Active Great Toe Dorsiflexion
• ─────────────────────────────────────────────────────────────────────────────
• 1. Great toe dorsiflexes (60°-70°)
• 2. Plantar fascia winds around 1st metatarsal head
• 3. Increased tension pulls calcaneus toward forefoot
• 4. Medial longitudinal arch elevates; subtalar joint supinates
• 5. Foot locks into a rigid lever for explosive forward propulsion
• ─────────────────────────────────────────────────────────────────────────────
• Pathophysiology: Degenerative Fasciosis, Not Fasciitis

Despite the historical "-itis" suffix, histopathological studies have conclusively demonstrated that plantar fasciitis is not an acute inflammatory condition . Microscopic evaluation of surgical specimens reveals:

Absence of inflammatory cellular infiltration (neutrophils and lymphocytes are absent);

Angiofibroblastic hyperplasia : disorganized, immature fibroblast proliferation with non-functional microvascular neovascularization;

Disordered, fragmented type III collagen replacing organized parallel type I collagen bundles;

Myxoid matrix degeneration and microtearing at the enthesis (calcaneal insertion).

Thus, the condition is properly conceptualized as a degenerative fasciosis resulting from repetitive mechanical tensile microtrauma exceeding the physiological reparative capacity of the tissue.

Risk Factors

Obesity (BMI >30 kg/m²) : The single strongest non-athletic independent risk factor (odds ratio >3.0) due to chronically elevated vertical ground reaction forces.

Occupational Weight-Bearing : Prolonged standing on unyielding hard concrete surfaces (e.g., factory workers, nurses, teachers, retail workers).

Biomechanics & Kinetic Chain : Pes planus (flat feet; creates excessive static tensile elongation of the fascia) or pes cavus (high rigid arch; fails to absorb ground impact, transmitting excessive shock to the heel).

Gastrocnemius-Soleus Contracture : Tightness of the triceps surae or Achilles tendon limits ankle dorsiflexion to <10°, forcing compensatory midfoot pronation and increased plantar fascial tension during gait.

Athletic Factors : Sudden increases in running mileage, intensity, or hill running; worn-out athletic footwear.

Clinical Presentation & Physical Examination

Cardinal History : The pathognomonic symptom is intense, sharp, stabbing heel pain with the very first steps out of bed in the morning or when standing after prolonged sitting or rest. During sleep, the foot rests in passive plantarflexion, allowing the plantar fascia to shorten and contract. Upon taking the first morning steps, abrupt full weight-bearing violently stretches the contracted, microtorn fascia, triggering severe lancinating pain. The pain characteristically improves after 5 to 15 minutes of light walking as the tissue warms and stretches, but aches progressively toward the end of the day or after prolonged standing.

Physical Examination :

Maximal Point Tenderness : Direct deep manual palpation elicits exquisite, sharp pain localized strictly over the anteromedial process of the calcaneal tuberosity (the anatomical origin of the central band of the fascia).

The Windlass Test : With the patient non-weight-bearing (or standing on a step), the examiner stabilizes the calcaneus and forcefully passively dorsiflexes the great toe at the first MTP joint. Reproduction of sharp heel pain at the calcaneal origin is a positive Windlass test (highly specific for plantar fasciitis).

Restricted Ankle Dorsiflexion : Assessment with the knee fully extended reveals limited dorsiflexion (<10°), confirming gastrocnemius tightness.

The Calcaneal Spur Fallacy

Plain radiographs are not routinely required for classic presentations and are reserved for refractory symptoms (>6 to 8 weeks) or to rule out calcaneal stress fractures or systemic spondyloarthropathies.

When radiographs are obtained, a calcaneal bone spur (plantar traction osteophyte) is identified projecting from the plantar calcaneus in approximately 50% of patients with plantar fasciitis .

CRITICAL BOARD EXAM PEARL : The calcaneal spur is an incidental finding and NOT the cause of pain ! Prominent spurs are present in 15% to 25% of completely asymptomatic, pain-free adults. The spur originates within the attachment of the flexor digitorum brevis muscle deep to the fascia, rather than inside the plantar fascia substance itself. Surgical excision of the spur provides no additional clinical benefit over isolated fascial release; treatment must focus entirely on the soft tissue pathology.

Evidence-Based Management Protocol

Over 90% of patients achieve complete symptom resolution within 6 to 12 months using non-surgical conservative therapy:

First-Line Conservative Therapy (Minimum 6 to 12 Weeks) :

Plantar Fascia-Specific Stretching : The patient crosses the affected leg over the opposite knee, grasps the base of the toes with the hand, and pulls the toes back toward the shin into maximal dorsiflexion, holding for 10 seconds (performed for 3 sets of 10 repetitions, specifically prior to taking the first morning steps ). DiGiovanni and colleagues demonstrated that fascia-specific stretching is significantly superior to general Achilles stretching alone.

Achilles Tendon Stretching : Standing wall stretches with knee extended and flexed.

Orthotic Supports : Prefabricated over-the-counter silicone heel cups or longitudinal arch supports. Randomized trials show that inexpensive prefabricated orthotics are as clinically effective as expensive custom-molded orthotics .

Night Splints : Rigid or semi-rigid splints maintain the ankle in neutral position (5° dorsiflexion) and the toes in slight extension overnight. This prevents nocturnal fascial contracture, dramatically reducing agonizing morning "first-step" pain.

Supportive Footwear : Strict avoidance of barefoot walking; use of supportive shoes with cushioned midsoles.

Short-Term NSAIDs : A 2- to 3-week course of oral ibuprofen or naproxen for acute analgesia.

Second-Line Interventions for Refractory Symptoms (>3 to 6 Months) :

Extracorporeal Shockwave Therapy (ESWT) : Delivers acoustic shockwaves to stimulate local neovascularization, tissue regeneration, and downregulate sensory nerve fibers. Safe and effective for chronic refractory cases.

Corticosteroid Injections (Caveat & Hazards) : A targeted injection of triamcinolone (20 to 40 mg) with local anesthetic via a medial approach under ultrasound guidance provides robust short-term pain relief (4 to 8 weeks). However, injections carry severe potential complications:

Plantar fascia rupture occurs in up to 10% of injected patients;

Heel fat pad atrophy causes permanent destruction of the shock-absorbing adipose architecture, resulting in intractable, lifelong heel strike pain. Injections should be strictly limited and never placed directly into the superficial fat pad.

Surgical Intervention : Open or endoscopic partial plantar fasciotomy is an absolute last resort, indicated in <5% of patients who fail at least 12 months of compliant conservative rehabilitation.

Exercise-Induced Lower Leg Pain: MTSS vs. Tibial Stress Fracture

Exercise-induced lower leg pain is a ubiquitous complaint among runners, military recruits, and jumping athletes. Clinicians must reliably distinguish between Medial Tibial Stress Syndrome (MTSS) and Tibial Stress Fractures . MTSS ("SHIN SPLINTS") VS. TIBIAL STRESS FRACTURE

• Clinical Feature Medial Tibial Stress Syndrome (MTSS) Tibial Stress Fracture
• ════════════════════════════════════════════════════════════════════════════════════════
• Pathophysiology Traction periostitis of fascial Microcrack accumulation in cortical
• insertion (soleus, FDL, tibialis post) bone exceeding osteoblastic repair

• Pain Character Diffuse, dull, aching pain; Sharp, localized, progressive pain;
• improves during workout warmup persists during and AFTER exercise

• Rest / Night Pain NEVER present at rest; Present at rest; frequent NOCTURNAL
• absent at night deep bone ache (Cardinal Red Flag)

• Palpation Area DIFFUSE tenderness spanning a FOCAL, exquisite point tenderness
• BROAD segment (>5 cm in length) over a NARROW segment (<2 cm)

Single-Leg Hop Test Mild discomfort; patient can hop UNABLE to hop due to severe pain

Radiographs (Early) Normal Normal in 50-70% (first 2-3 weeks)

• MRI Findings Periosteal edema only (T2/STIR); Deep bone marrow edema + discrete
• cortex and marrow are intact intracortical fracture line (T1/T2)
• ════════════════════════════════════════════════════════════════════════════════════════
• Medial Tibial Stress Syndrome (MTSS / "Shin Splints")

Pathophysiology : A traction-induced periostitis along the posteromedial tibial border where the deep crural fascia and the soleus, flexor digitorum longus (FDL), and posterior tibialis muscles insert. Repetitive ground reaction forces and eccentric muscle contraction create continuous traction stress on the periosteum.

Clinical Features : Insidious onset of diffuse, dull, aching pain along the posteromedial border of the middle-to-distal third of the tibia; characteristically bilateral. Pain is typically present at the onset of running, eases as the athlete warms up, but returns and throbs during the post-exercise cool-down.

Examination : Diffuse tenderness along the posteromedial tibial margin extending over a broad longitudinal distance (>5 cm) . There is no focal cortical step-off, localized swelling, or neurovascular deficit.

Management : Completely non-operative. Relative rest, substitution of low-impact cardiovascular cross-training (swimming, deep-water running, stationary cycling), ice massage, stretching of the gastrocnemius-soleus complex, and over-the-counter orthotics to correct excessive foot pronation. Gradual return to running over 4 to 6 weeks once daily walking is entirely asymptomatic.

Tibial Stress Fracture: Low-Risk vs. High-Risk Lesions

Tibial stress fractures represent mechanical fatigue failure of cortical bone caused by repetitive cyclical submaximal loading exceeding the rate of osteoblastic remodeling. They account for up to 50% of all athletic stress fractures. TIBIAL STRESS FRACTURE RISK STRATIFICATION

• [ANTERIOR TIBIAL CORTEX] [POSTEROMEDIAL TIBIAL CORTEX]
• High-Risk Stress Fracture • Low-Risk Stress Fracture
• Tension side of bending tibia • Compression side of bending tibia
• Hypovascular anterior border • Robust posteromedial blood supply
• "Dreaded Black Line" on X-ray • Periosteal callus heals readily
• High rate of NONUNION / RE-FRACTURE • Excellent spontaneous union
• Management: Strict NWB cast/boot • Management: Protected weight-bearing,
• or Intramedullary Nailing walking boot, progressive rest

Low-Risk Stress Fractures: Posteromedial Tibial Cortex :

Located on the compression side of the tibia during ambulation.

Characterized by robust periosteal vascularity and an excellent natural healing tendency.

Management : Relative rest with protected weight-bearing in a pneumatic walking boot or crutches for 2 to 4 weeks until non-tender to palpation, followed by a phased 6- to 8-week gradual return-to-running program.

High-Risk Stress Fractures: Anterior Tibial Cortex :

Located on the tension side of the tibia, subject to continuous distracting forces during weight-bearing.

The anterior mid-shaft of the tibia has poor cutaneous coverage and a precarious, hypovascular periosteal blood supply.

"The Dreaded Black Line" : Plain lateral radiographs characteristically demonstrate a discrete transverse radiolucent fracture line across the anterior cortex with surrounding anterior cortical hypertrophy. These lesions have an exceptionally high propensity for delayed union, permanent nonunion, and sudden catastrophic complete transverse fracture !

Management : Aggressive therapy is mandatory. Strict non-weight-bearing immobilization in a cast or boot for 6 to 8 weeks ; bone stimulators; or urgent orthopedic referral for intramedullary nailing (rod placement) , which is the definitive standard of care for competitive athletes or non-united anterior cortical fractures.

Diagnostic Imaging Protocol for Stress Fractures

Plain Radiographs : Mandatory initial test, but falsely negative in 50% to 70% of stress fractures during the first 2 to 3 weeks of symptoms. Faint periosteal reaction, cortical thickening, or fracture lines only become visible after 3 to 4 weeks.

Magnetic Resonance Imaging (MRI) : The definitive gold standard imaging modality (sensitivity and specificity >95%). MRI visualizes high-signal bone marrow edema on T2-weighted and STIR sequences within 48 to 72 hours of symptom onset (Fredericson Grade 1 to 4 bone stress injuries), long before plain radiographs show cortical changes.

Triple-Phase Bone Scintigraphy : Highly sensitive (showing a focal "hot spot"), but inferior to MRI in specificity and unable to delineate cortical anatomy.

Morton Neuroma (Interdigital Neuroma)

Morton neuroma is an entrapment compressive neuropathy of the common plantar digital nerve. Despite the "neuroma" designation, it is not a true neoplasm , but rather an angiofibroblastic perineural fibrosis.

Pathophysiology & Anatomical Vulnerability

Anatomical Site : Involves the third intermetatarsal web space (between the 3rd and 4th metatarsal heads) in 80% to 90% of cases . The second intermetatarsal space is the second most common site (~10% to 15%); it virtually never occurs in the first or fourth interspaces.

Mechanisms of Predilection :

The third common digital nerve is formed by an anastomosis between branches of the medial plantar nerve and lateral plantar nerve , making it anatomically thicker and less mobile.

The nerve is compressed against the rigid, unyielding deep transverse metatarsal ligament directly superior to it and the ground reaction forces inferiorly.

Risk Factors : Women are affected 5 to 8 times more frequently than men , predominantly between 40 and 60 years of age. Strongly exacerbated by footwear that squeezes the forefoot—specifically narrow, pointed toe-box shoes and high-heeled shoes (which force the metatarsophalangeal joints into extreme hyperextension, tethering the nerve against the transverse ligament).

Clinical Presentation & Physical Examination

Symptom Complex : Burning, aching, or lancinating plantar forefoot pain that radiates distally into the adjacent toes (third and fourth digits), frequently accompanied by paresthesias, tingling, or numbness in the web space. Patients characteristically describe the distinct sensation of "walking on a marble," a pebble, or a rolled-up sock inside the shoe .

Relieving Factors : Symptoms are intensely aggravated by tight shoes and walking on hard floors, and are immediately relieved by removing the shoes, walking barefoot, and vigorously rubbing/massaging the forefoot .

Physical Examination :

The Mulder Sign (Mulder Click) : The examiner grasps the medial and lateral borders of the patient's forefoot with one hand, squeezing the metatarsal heads together to compress the transverse arch. Simultaneously, with the other hand's thumb and index finger, the examiner applies direct plantar-to-dorsal pressure into the third intermetatarsal space. A positive test elicits a sharp pain and a palpable, audible "click" as the enlarged, fibrotic neuroma is compressed and subluxated between the adjacent metatarsal heads.

Direct deep manual palpation of the third plantar interspace reproduces the patient's familiar burning neuralgia.

Stepwise Management Strategy

First-Line Conservative Management (Successful in 60% to 70%) :

Footwear Modification : Transition to wide toe-box shoes with low heels (allowing the metatarsal heads to splay naturally and relieving transverse compression).

Metatarsal Pads : Placement of a teardrop-shaped silicone or felt metatarsal pad positioned immediately proximal to the metatarsal heads (NOT directly beneath them). This elevates the metatarsal shafts, splays the metatarsal heads, and decompresses the interdigital nerve beneath the transverse ligament.

Oral Pharmacotherapy : Short-term oral NSAIDs for neuropathic irritation.

Second-Line: Intermetatarsal Corticosteroid Injection :

Injection of 1 mL of local anesthetic combined with 20 to 40 mg of triamcinolone into the affected intermetatarsal space via a dorsal approach (inserting the needle between the 3rd and 4th metatarsal heads). The dorsal approach avoids penetrating the plantar weight-bearing fat pad, preventing fat pad atrophy. Achieves significant relief in 60% to 75% of patients.

Third-Line / Surgical Decompression :

Indicated for persistent, disabling pain failing 6 to 12 months of conservative therapy.

Procedures include surgical neurectomy (excision of the fibrotic nerve segment) or decompression release of the deep transverse metatarsal ligament . Neurectomy achieves pain relief in >80% of patients, with expected permanent numbness in the adjacent web space.

Loading diagram... Overuse Lower Extremity Pain Diagnostic & Management Algorithm